{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T09:57:10Z","timestamp":1791021430941,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T00:00:00Z","timestamp":1762560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T00:00:00Z","timestamp":1762560000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-14939-7","type":"journal-article","created":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T13:24:34Z","timestamp":1762608274000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Identification and validation of stemness-related gene signatures to predict prognosis and immune infiltration in osteosarcoma reveals a critical role for S100A13"],"prefix":"10.1186","volume":"25","author":[{"given":"Jialin","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyu","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yawen","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianli","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingzheng","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,8]]},"reference":[{"issue":"Suppl 7","key":"14939_CR1","doi-asserted-by":"publisher","first-page":"vii320","DOI":"10.1093\/annonc\/mdq276","volume":"21","author":"J Ritter","year":"2010","unstructured":"Ritter J, Bielack SS. Osteosarcoma. Ann Oncol. 2010;21(Suppl 7):vii320-325.","journal-title":"Ann Oncol"},{"key":"14939_CR2","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1056\/NEJMra2103423","volume":"385","author":"PS Meltzer","year":"2021","unstructured":"Meltzer PS, Helman LJ. New horizons in the treatment of osteosarcoma. N Engl J Med. 2021;385:2066\u201376.","journal-title":"N Engl J Med"},{"key":"14939_CR3","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/01.JAA.0000508202.17804.4d","volume":"29","author":"C Hiller","year":"2016","unstructured":"Hiller C, Wegler JL, Forest CP. Osteosarcoma: accurately diagnosing this bone-chilling disease. JAAPA. 2016;29:29\u201335.","journal-title":"JAAPA"},{"key":"14939_CR4","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1016\/j.ejca.2009.03.005","volume":"45","author":"EE Pakos","year":"2009","unstructured":"Pakos EE, Nearchou AD, Grimer RJ, Koumoullis HD, Abudu A, Bramer JA, et al. Prognostic factors and outcomes for osteosarcoma: an international collaboration. Eur J Cancer. 2009;45:2367\u201375.","journal-title":"Eur J Cancer"},{"key":"14939_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2020.12.024","volume":"500","author":"C Chen","year":"2021","unstructured":"Chen C, Xie L, Ren T, Huang Y, Xu J, Guo W. Immunotherapy for osteosarcoma: fundamental mechanism, rationale, and recent breakthroughs. Cancer Lett. 2021;500:1\u201310.","journal-title":"Cancer Lett"},{"key":"14939_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.27227","volume":"65","author":"MF Wedekind","year":"2018","unstructured":"Wedekind MF, Wagner LM, Cripe TP. Immunotherapy for osteosarcoma: where do we go from here? Pediatr Blood Cancer. 2018;65:e27227.","journal-title":"Pediatr Blood Cancer"},{"key":"14939_CR7","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.trecan.2019.05.010","volume":"5","author":"GL Szeto","year":"2019","unstructured":"Szeto GL, Finley SD. Integrative approaches to cancer immunotherapy. Trends Cancer. 2019;5:400\u201310.","journal-title":"Trends Cancer"},{"key":"14939_CR8","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/s41423-020-0488-6","volume":"17","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Zhang Z. The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications. Cell Mol Immunol. 2020;17:807\u201321.","journal-title":"Cell Mol Immunol"},{"key":"14939_CR9","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1080\/07357907.2020.1768401","volume":"38","author":"LR Sadykova","year":"2020","unstructured":"Sadykova LR, Ntekim AI, Muyangwa-Semenova M, Rutland CS, Jeyapalan JN, Blatt N, et al. Epidemiology and risk factors of osteosarcoma. Cancer Invest. 2020;38:259\u201369.","journal-title":"Cancer Invest"},{"key":"14939_CR10","doi-asserted-by":"publisher","first-page":"1394339","DOI":"10.3389\/fcell.2024.1394339","volume":"12","author":"H Liang","year":"2024","unstructured":"Liang H, Cui M, Tu J, Chen X. Advancements in osteosarcoma management: integrating immune microenvironment insights with immunotherapeutic strategies. Front Cell Dev Biol. 2024;12:1394339.","journal-title":"Front Cell Dev Biol"},{"key":"14939_CR11","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s12943-022-01682-x","volume":"21","author":"P Nallasamy","year":"2022","unstructured":"Nallasamy P, Nimmakayala RK, Parte S, Are AC, Batra SK, Ponnusamy MP. Tumor microenvironment enriches the stemness features: the architectural event of therapy resistance and metastasis. Mol Cancer. 2022;21:225.","journal-title":"Mol Cancer"},{"key":"14939_CR12","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.canlet.2016.11.019","volume":"386","author":"HK Brown","year":"2017","unstructured":"Brown HK, Tellez-Gabriel M, Heymann D. Cancer stem cells in osteosarcoma. Cancer Lett. 2017;386:189\u201395.","journal-title":"Cancer Lett"},{"key":"14939_CR13","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12943-017-0600-4","volume":"16","author":"PR Prasetyanti","year":"2017","unstructured":"Prasetyanti PR, Medema JP. Intra-tumor heterogeneity from a cancer stem cell perspective. Mol Cancer. 2017;16:41.","journal-title":"Mol Cancer"},{"key":"14939_CR14","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.canlet.2015.11.003","volume":"370","author":"GN Yan","year":"2016","unstructured":"Yan GN, Lv YF, Guo QN. Advances in osteosarcoma stem cell research and opportunities for novel therapeutic targets. Cancer Lett. 2016;370:268\u201374.","journal-title":"Cancer Lett"},{"key":"14939_CR15","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.semcancer.2014.07.001","volume":"31","author":"E Vlashi","year":"2015","unstructured":"Vlashi E, Pajonk F. Cancer stem cells, cancer cell plasticity and radiation therapy. Semin Cancer Biol. 2015;31:28\u201335.","journal-title":"Semin Cancer Biol"},{"key":"14939_CR16","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41568-018-0056-x","volume":"18","author":"NK Lytle","year":"2018","unstructured":"Lytle NK, Barber AG, Reya T. Stem cell fate in cancer growth, progression and therapy resistance. Nat Rev Cancer. 2018;18:669\u201380.","journal-title":"Nat Rev Cancer"},{"key":"14939_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.123015","volume":"355","author":"MA Sarabia-Sanchez","year":"2024","unstructured":"Sarabia-Sanchez MA, Tinajero-Rodriguez JM, Ortiz-Sanchez E, Alvarado-Ortiz E. Cancer stem cell markers: symphonic masters of chemoresistance and immune evasion. Life Sci. 2024;355:123015.","journal-title":"Life Sci"},{"key":"14939_CR18","doi-asserted-by":"publisher","first-page":"8381","DOI":"10.1002\/jcp.27740","volume":"234","author":"M Najafi","year":"2019","unstructured":"Najafi M, Farhood B, Mortezaee K. Cancer stem cells (CSCs) in cancer progression and therapy. J Cell Physiol. 2019;234:8381\u201395.","journal-title":"J Cell Physiol"},{"key":"14939_CR19","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/s41419-018-0363-x","volume":"9","author":"W Liu","year":"2018","unstructured":"Liu W, Zhao Z, Wang Y, Li W, Su Q, Jia Q, et al. Dioscin inhibits stem-cell-like properties and tumor growth of osteosarcoma through Akt\/GSK3\/beta-catenin signaling pathway. Cell Death Dis. 2018;9:343.","journal-title":"Cell Death Dis"},{"key":"14939_CR20","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s13045-020-00990-3","volume":"13","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Wang X. Targeting the Wnt\/beta-catenin signaling pathway in cancer. J Hematol Oncol. 2020;13:165.","journal-title":"J Hematol Oncol"},{"key":"14939_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01828-x","volume":"9","author":"Q Shi","year":"2024","unstructured":"Shi Q, Xue C, Zeng Y, Yuan X, Chu Q, Jiang S, et al. Notch signaling pathway in cancer: from mechanistic insights to targeted therapies. Signal Transduct Target Ther. 2024;9:128.","journal-title":"Signal Transduct Target Ther"},{"key":"14939_CR22","doi-asserted-by":"crossref","unstructured":"Takebe N, Miele L, Harris PJ, Jeong W, Bando H, Kahn M, et al. Targeting notch, hedgehog, and Wnt pathways in cancer stem cells: clinical update. Nat Rev Clin Oncol. 2015;12:445\u201364.","DOI":"10.1038\/nrclinonc.2015.61"},{"key":"14939_CR23","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s41568-021-00366-w","volume":"21","author":"D Bayik","year":"2021","unstructured":"Bayik D, Lathia JD. Cancer stem cell-immune cell crosstalk in tumour progression. Nat Rev Cancer. 2021;21:526\u201336.","journal-title":"Nat Rev Cancer"},{"key":"14939_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-0110-5","volume":"5","author":"L Yang","year":"2020","unstructured":"Yang L, Shi P, Zhao G, Xu J, Peng W, Zhang J, et al. Targeting cancer stem cell pathways for cancer therapy. Signal Transduct Target Ther. 2020;5:8.","journal-title":"Signal Transduct Target Ther"},{"key":"14939_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21196985","author":"C Yang","year":"2020","unstructured":"Yang C, Tian Y, Zhao F, Chen Z, Su P, Li Y, et al. Bone microenvironment and osteosarcoma metastasis. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21196985.","journal-title":"Int J Mol Sci"},{"key":"14939_CR26","doi-asserted-by":"publisher","first-page":"e28493","DOI":"10.1016\/j.heliyon.2024.e28493","volume":"10","author":"Y Yao","year":"2024","unstructured":"Yao Y, Wang D, Zheng L, Zhao J, Tan M. Advances in prognostic models for osteosarcoma risk. Heliyon. 2024;10:e28493.","journal-title":"Heliyon"},{"key":"14939_CR27","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.stem.2018.11.017","volume":"24","author":"C Saygin","year":"2019","unstructured":"Saygin C, Matei D, Majeti R, Reizes O, Lathia JD. Targeting cancer stemness in the clinic: from hype to hope. Cell Stem Cell. 2019;24:25\u201340.","journal-title":"Cell Stem Cell"},{"key":"14939_CR28","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.gendis.2022.12.021","volume":"11","author":"F Pu","year":"2024","unstructured":"Pu F, Guo H, Shi D, Chen F, Peng Y, Huang X, et al. The generation and use of animal models of osteosarcoma in cancer research. Genes Dis. 2024;11:664\u201374.","journal-title":"Genes Dis"},{"key":"14939_CR29","doi-asserted-by":"publisher","first-page":"2902","DOI":"10.1080\/21655979.2022.2026730","volume":"13","author":"X He","year":"2022","unstructured":"He X, Cheng X, Ding J, Xiong M, Chen B, Cao G. Hyperglycemia induces miR-26-5p down-regulation to overexpress PFKFB3 and accelerate epithelial-mesenchymal transition in gastric cancer. Bioengineered. 2022;13:2902\u201317.","journal-title":"Bioengineered"},{"key":"14939_CR30","doi-asserted-by":"crossref","unstructured":"Donato R, Cannon BR, Sorci G, Riuzzi F, Hsu K, Weber DJ, et al. Functions of S100 proteins. Curr Mol Med. 2013;13:24\u201357.","DOI":"10.2174\/156652413804486214"},{"key":"14939_CR31","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/modpathol.2010.54","volume":"23","author":"D Massi","year":"2010","unstructured":"Massi D, Landriscina M, Piscazzi A, Cosci E, Kirov A, Paglierani M, et al. S100A13 is a new angiogenic marker in human melanoma. Mod Pathol. 2010;23:804\u201313.","journal-title":"Mod Pathol"},{"key":"14939_CR32","doi-asserted-by":"crossref","unstructured":"Landriscina M, Schinzari G, Di Leonardo G, Quirino M, Cassano A, D\u2019Argento E, et al. S100A13, a new marker of angiogenesis in human astrocytic gliomas. J Neurooncol. 2006;80:251\u20139.","DOI":"10.1007\/s11060-006-9189-y"},{"key":"14939_CR33","doi-asserted-by":"publisher","first-page":"22544","DOI":"10.1074\/jbc.M100546200","volume":"276","author":"M Landriscina","year":"2001","unstructured":"Landriscina M, Soldi R, Bagala C, Micucci I, Bellum S, Tarantini F, et al. S100A13 participates in the release of fibroblast growth factor 1 in response to heat shock in vitro. J Biol Chem. 2001;276:22544\u201352.","journal-title":"J Biol Chem"},{"key":"14939_CR34","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.bbrc.2009.02.061","volume":"381","author":"I Graziani","year":"2009","unstructured":"Graziani I, Doyle A, Sterling S, Kirov A, Tarantini F, Landriscina M, et al. Protein folding does not prevent the nonclassical export of FGF1 and S100A13. Biochem Biophys Res Commun. 2009;381:350\u20134.","journal-title":"Biochem Biophys Res Commun"},{"key":"14939_CR35","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.biomaterials.2017.09.030","volume":"149","author":"P Liu","year":"2017","unstructured":"Liu P, Zhang R, Yu W, Ye Y, Cheng Y, Han L, et al. FGF1 and IGF1-conditioned 3d culture system promoted the amplification and cancer stemness of lung cancer cells. Biomaterials. 2017;149:63\u201376.","journal-title":"Biomaterials"},{"key":"14939_CR36","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1111\/1759-7714.12797","volume":"9","author":"S Miao","year":"2018","unstructured":"Miao S, Qiu T, Zhao Y, Wang H, Sun X, Wang Y, et al. Overexpression of S100A13 protein is associated with tumor angiogenesis and poor survival in patients with early-stage non-small cell lung cancer. Thorac Cancer. 2018;9:1136\u201344.","journal-title":"Thorac Cancer"},{"key":"14939_CR37","doi-asserted-by":"crossref","unstructured":"Zhong J, Liu C, Chen YJ, Zhang QH, Yang J, Kang X, et al. The association between S100A13 and HMGA1 in the modulation of thyroid cancer proliferation and invasion. J Transl Med. 2016;14:80.","DOI":"10.1186\/s12967-016-0824-x"},{"key":"14939_CR38","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1111\/jop.13224","volume":"50","author":"R Li","year":"2021","unstructured":"Li R, Li W, He F, Zhang M, Luo H, Tang H. Systematic screening identifies a TEAD4-S100A13 axis modulating cisplatin sensitivity of oral squamous cell carcinoma cells. J Oral Pathol Med. 2021;50:882\u201390.","journal-title":"J Oral Pathol Med"},{"key":"14939_CR39","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1038\/bjc.2014.169","volume":"110","author":"A Azimi","year":"2014","unstructured":"Azimi A, Pernemalm M, Frostvik Stolt M, Hansson J, Lehtio J, Egyhazi Brage S, et al. Proteomics analysis of melanoma metastases: association between S100A13 expression and chemotherapy resistance. Br J Cancer. 2014;110:2489\u201395.","journal-title":"Br J Cancer"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14939-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14939-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14939-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T17:08:54Z","timestamp":1762880934000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-14939-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,8]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14939"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14939-7","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,8]]},"assertion":[{"value":"25 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1734"}}